Y. Zhou

Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.

M. Pike, M. Fletcher, J. Parker, 1994, Blood.

Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group.

C. Pegelow, E. Operskalski, M. Hilgartner, 1995, Blood.

Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group.

D. Stram, E. Schiff, E. Operskalski, 1995, The Journal of infectious diseases.